Overview

* Shoulder Innovations Q2 2025 revenue up 33% to $11 mln, driven by implant sales

* Net loss widened to $19.2 mln due to preferred stock warrant liability changes

* Co completed IPO raising $75 mln, enhancing financial position for growth

Outlook

* Shoulder Innovations ( SI ) expects 2025 revenue between $42 mln and $44 mln

Result Drivers

* IMPLANT SALES - Revenue growth driven by 34% increase in implant system sales

* CUSTOMER EXPANSION - Nearly 50% increase in surgeon customers year-over-year

* FINANCIAL POSITION - IPO and convertible notes financing strengthened balance sheet

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 EPS -$165.53

Q2 Net -$19.20

Income mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

* Wall Street's median 12-month price target for Shoulder Innovations Inc ( SI ) is $18.50, about 14.1% above its September 8 closing price of $15.90

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)